FDA Updates Nationwide Eye Drop Recall Due to Sterility Concerns, Affecting Millions of Bottles
The U.S. Food & Drug Administration (FDA) has updated a significant nationwide recall of eye drops, initially issued by Sterling Pharmaceutical Services LLC in August due to potential sterility concerns. On September 21, the FDA classified this as a Class II recall, indicating that using the affected products 'may cause temporary or medically reversible adverse health consequences.' While serious injury is deemed unlikely, consumers are advised to avoid using these drops. The recall impacts millions of bottles sold under various brand names, including those distributed to major drugstores and retailers across the country, such as Walgreens. The FDA's enforcement report provides a comprehensive list of affected products, including specific lot numbers and expiration dates for brands like AvKare, Reliable-1 Laboratories, Walgreens Lubricant Eye Drops, TRP The Relief Products, Major LubriFresh P.M. Nighttime Ointment, and Cameron Pharmaceuticals Lubricant Eye Drops. Consumers are urged to check their medicine...
